MIT AI expert warns automating Gen Z entry-level jobs could backfire—and cost companies their future workforce1 May 2026
How Ketamine May Be The Answer To Treatment-Resistant DepressionBy Press Room9 April 2024 Although it is not yet approved by the FDA, off-label, supervised use of ketamine, a Schedule III substance, is allowed…